A study is enrolling over 100 people with type 2 between the ages of 10 and 18 years, examining Jardiance and Tradjenta

How Kerri Sparling navigates CGM sharing with friends and family and how it’s helped her feel less self-conscious about her numbers

A once-daily pill combining metformin, Farxiga, and Onglyza helps lower A1C and support weight loss

How we talk about diabetes matters; using empowering, non-stigmatizing words is important when speaking with and about people with diabetes

When will we see a 670G with Bluetooth and remote monitoring? Also, the upcoming MiniMed 780G with automatic boluses, a seven-day wear infusion set, and better Medtronic...

Effective tips for surviving food-focused gatherings, defeating stress, cooking smart, sneaking in exercise, and optimizing sleep. Plus, clever recipes and great book...

One Drop’s Chrome becomes the first blood glucose meter to send data directly to Apple Watch without a nearby phone. Plus, new health features on the Series 4 Apple...

The latest on Dexcom’s work with Verily to make a more simple and accessible CGM; also, the “Pro Q” professional CGM and insulin dosing advice for people on multiple...

A recent study found 38% of those with type 1 diagnosed after age 30 were not initially given insulin; learn ways of differentiating between type 1 and type 2 at...

Zealand Pharma shared positive trial results for its dasiglucagon – 99% of participants recovered from hypo within 15 minutes of treatment

Transitioning care from parent to child can be a stressful time for families with diabetes – six strategies on how to reduce the burden

Dr. Diana Isaacs on CGM, “shared” appointments, and identifying “Bright Spots” and “Landmines.” Plus, how to find a Diabetes Care and Education Specialist near you

If approved, Lilly’s intranasal glucagon would be a radical ease-of-use improvement over current glucagon kits for severe hypoglycemia

The VALyou program, designed to help people paying full-price for insulin not eligible for other patient assistance programs, now includes basal insulin Toujeo and rapid...

A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!

New guidelines by the US Department of Health and Human Services emphasize the benefit of ANY increased physical activity

Amarin’s Vascepa, an omega-3 fatty acid, is shown to lower risk of heart attack, stroke, and heart-related death for adults with high risk for heart disease with...

Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...

Try googling “prediabetes” or “type 2 diabetes” — a new search feature in the United States automatically spotlights the CDC’s one-minute prediabetes risk test

Diabetes advocates, Renza and Grumpy, share the importance of #LanguageMatters and the consequences of “grading” diabetes management